FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017208087> ?p ?o ?g. }

• W2017208087 endingPage "2028" @default.
• W2017208087 startingPage "2020" @default.
• W2017208087 abstract "The present study investigated the role of second messenger-dependent protein kinase A (PKA) and C (PKC) in the regulation of endogenous secretin receptor responsiveness in NG108-15 mouse neuroblastoma×rat glioma hybrid cells. In whole cell cyclic AMP accumulation studies, activation of PKC either by phorbol 12-myristate 13-acetate (PMA) or by purinoceptor stimulation using uridine 5′-triphosphate (UTP) decreased secretin receptor responsiveness. PKC activation also inhibited forskolin-stimulated cyclic AMP accumulation but did not affect cyclic AMP responses mediated by the prostanoid-IP receptor agonist iloprost, or the A2 adenosine receptor agonist 5′-(N-ethylcarboxamido) adenosine (NECA). In additivity experiments, saturating concentrations of secretin and iloprost were found to be additive in terms of cyclic AMP accumulation, whereas saturating concentrations of NECA and iloprost together were not. This suggests compartmentalization of Gs-coupling components in NG108-15 cells and possible heterologous regulation of secretin receptor responsiveness at the level of adenylyl cyclase activation. Cells exposed to the PKA inhibitor H-89, exhibited a time-dependent increase in secretin receptor responsiveness compared to control cells. This effect was selective since cyclic AMP responses to forskolin, iloprost and NECA were not affected by H-89 treatment. Furthermore, treatment with the protein synthesis inhibitor cycloheximide produced a time-dependent increase in secretin receptor responsiveness. Together these results indicate that endogenous secretin receptor responsiveness is regulated by PKC, PKA and protein neosynthesis in NG108-15 cells. British Journal of Pharmacology (2002) 135, 2020–2028; doi:10.1038/sj.bjp.0704655" @default.
• W2017208087 created "2016-06-24" @default.
• W2017208087 creator A5015895457 @default.
• W2017208087 creator A5053765063 @default.
• W2017208087 date "2002-04-01" @default.
• W2017208087 modified "2023-10-18" @default.
• W2017208087 title "Second messenger-dependent protein kinases and protein synthesis regulate endogenous secretin receptor responsiveness" @default.
• W2017208087 cites W1481438484 @default.
• W2017208087 cites W1534540527 @default.
• W2017208087 cites W1550506586 @default.
• W2017208087 cites W1606256000 @default.
• W2017208087 cites W1755902553 @default.
• W2017208087 cites W1893782948 @default.
• W2017208087 cites W1928342325 @default.
• W2017208087 cites W1945832201 @default.
• W2017208087 cites W1967497612 @default.
• W2017208087 cites W1968146664 @default.
• W2017208087 cites W1968674267 @default.
• W2017208087 cites W1968950287 @default.
• W2017208087 cites W1970678244 @default.
• W2017208087 cites W1978228078 @default.
• W2017208087 cites W1980301228 @default.
• W2017208087 cites W1980445909 @default.
• W2017208087 cites W1982377806 @default.
• W2017208087 cites W1994873358 @default.
• W2017208087 cites W2001578819 @default.
• W2017208087 cites W2013450910 @default.
• W2017208087 cites W2018705158 @default.
• W2017208087 cites W2025937582 @default.
• W2017208087 cites W2033983560 @default.
• W2017208087 cites W2055863819 @default.
• W2017208087 cites W2087305939 @default.
• W2017208087 cites W2089311853 @default.
• W2017208087 cites W2090020265 @default.
• W2017208087 cites W2100316115 @default.
• W2017208087 cites W2125468282 @default.
• W2017208087 cites W2128635872 @default.
• W2017208087 cites W2134326270 @default.
• W2017208087 cites W2154810167 @default.
• W2017208087 cites W2170355588 @default.
• W2017208087 cites W2342123394 @default.
• W2017208087 cites W2414143381 @default.
• W2017208087 cites W2416456237 @default.
• W2017208087 cites W2418464682 @default.
• W2017208087 cites W2883002636 @default.
• W2017208087 cites W4293247451 @default.
• W2017208087 cites W48282315 @default.
• W2017208087 cites W2038144617 @default.
• W2017208087 doi "https://doi.org/10.1038/sj.bjp.0704655" @default.
• W2017208087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1573319" @default.
• W2017208087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11959806" @default.
• W2017208087 hasPublicationYear "2002" @default.
• W2017208087 type Work @default.
• W2017208087 sameAs 2017208087 @default.
• W2017208087 citedByCount "6" @default.
• W2017208087 countsByYear W20172080872018 @default.
• W2017208087 countsByYear W20172080872022 @default.
• W2017208087 crossrefType "journal-article" @default.
• W2017208087 hasAuthorship W2017208087A5015895457 @default.
• W2017208087 hasAuthorship W2017208087A5053765063 @default.
• W2017208087 hasBestOaLocation W20172080871 @default.
• W2017208087 hasConcept C126322002 @default.
• W2017208087 hasConcept C134018914 @default.
• W2017208087 hasConcept C163235415 @default.
• W2017208087 hasConcept C170493617 @default.
• W2017208087 hasConcept C184235292 @default.
• W2017208087 hasConcept C185592680 @default.
• W2017208087 hasConcept C195794163 @default.
• W2017208087 hasConcept C24998067 @default.
• W2017208087 hasConcept C2776991684 @default.
• W2017208087 hasConcept C2778677841 @default.
• W2017208087 hasConcept C2778938600 @default.
• W2017208087 hasConcept C2779276759 @default.
• W2017208087 hasConcept C49039625 @default.
• W2017208087 hasConcept C62478195 @default.
• W2017208087 hasConcept C71924100 @default.
• W2017208087 hasConcept C86803240 @default.
• W2017208087 hasConcept C95444343 @default.
• W2017208087 hasConcept C97029542 @default.
• W2017208087 hasConceptScore W2017208087C126322002 @default.
• W2017208087 hasConceptScore W2017208087C134018914 @default.
• W2017208087 hasConceptScore W2017208087C163235415 @default.
• W2017208087 hasConceptScore W2017208087C170493617 @default.
• W2017208087 hasConceptScore W2017208087C184235292 @default.
• W2017208087 hasConceptScore W2017208087C185592680 @default.
• W2017208087 hasConceptScore W2017208087C195794163 @default.
• W2017208087 hasConceptScore W2017208087C24998067 @default.
• W2017208087 hasConceptScore W2017208087C2776991684 @default.
• W2017208087 hasConceptScore W2017208087C2778677841 @default.
• W2017208087 hasConceptScore W2017208087C2778938600 @default.
• W2017208087 hasConceptScore W2017208087C2779276759 @default.
• W2017208087 hasConceptScore W2017208087C49039625 @default.
• W2017208087 hasConceptScore W2017208087C62478195 @default.
• W2017208087 hasConceptScore W2017208087C71924100 @default.
• W2017208087 hasConceptScore W2017208087C86803240 @default.
• W2017208087 hasConceptScore W2017208087C95444343 @default.
• W2017208087 hasConceptScore W2017208087C97029542 @default.
• W2017208087 hasIssue "8" @default.

• next